Serotonergic Modulation of Brain Development: Genetic and Pharmacologic Influenc

大脑发育的血清素调节:遗传和药理影响

基本信息

项目摘要

DESCRIPTION (provided by applicant): The current application proposes to create a Silvio O. Conte Center for Basic and Translational Mental Health Research to address the role of serotonin (5HT) signaling in brain development. Before 5HT assumes its canonical role as a neurotransmitter, it acts during early stages of neural growth to exert profound effects on brain structure and function. The Center hypothesizes that two modulators of developmental 5HT signaling include: genetic variants and serotonin selective reuptake inhibitors (SSRIs). In the first case, naturally occurring serotonergic polymorphisms are associated with measurable differences in human brain structure and function. In the second case, the fetus receives incidental exposure from maternal use of SSRI medications. Based on animal models and human imaging, the effects of augmented 5HT signaling on brain development may increase vulnerability to mental disorders as a long-term consequence. The Center will investigate both sources of 5HT signaling modulation and hypothesizes that fetal SSRI exposure and 5HTergic genetic variants will produce convergent effects on brain structure, function, and consequently behavior. The Center includes 4 projects and 4 cores that integrate epidemiology, clinical, and animal models to address the central hypothesis. The Center studies ~11,000 children with in utero exposure to SSRIs by following mental and physical health problems through adolescence. A companion project studies newborns exposed to SSRIs in utero using multi-modal neuroimaging and EEG to assess brain structure and function at the earliest ages. The brain effects of early-life SSRI exposure is studied in mouse models using the same multi-modal imaging measures as well as microscopic analyses of cellular properties that may underlie imaging abnormalities. The Center reasons that the influence of genetic modulators of 5HT is likely encoded during early development. We test this hypothesis through genetically stratified newborns and fetal rhesus macaques, and examining genetics, brain imaging, and EEG in a unique, clinically characterized, population at high and low risk for depression. The Center studies of early-life 5HT signaling and brain development should lead to a better understanding of whether some mental disorders have their origins in development-a question highly relevant to the mission of NIMH. PUBLIC HEALTH RELEVANCE: Estimates suggest that >100,000 infants are exposed to SSRIs in utero each year in the U.S. Yet, virtually nothing is known about the effects of SSRIs on fetal brain or their long-term consequences. The role of serotonin in brain development is clearly established in other species and likely applied to humans as well. The proposed Center would address an important public health question about long-term effects of SSRIs on the fetus and provide better understanding of how serotonin can influence brain maturation and behavior.
描述(由申请人提供):当前的申请提议创建一个Silvio O. Conte基础和转化心理健康研究中心,以解决5-羟色胺(5HT)信号在大脑发育中的作用。在5HT担任其作为神经递质的规范作用之前,它在神经生长的早期阶段起作用,对脑结构和功能产生深远的影响。该中心假设两个发育5HT信号的调节剂包括:遗传变异和5-羟色胺选择性再摄取抑制剂(SSRIS)。在第一种情况下,天然存在的血清素能多态性与人脑结构和功能的可测量差异有关。在第二种情况下,胎儿会因母体使用SSRI药物而受到偶然暴露。基于动物模型和人类成像,增强5HT信号传导对脑发育的影响可能会增加对精神障碍的脆弱性,这是长期后果。该中心将研究5HT信号调制的来源,并假设胎儿SSRI暴露和5HTRGIC遗传变异将对大脑结构,功能和因此行为产生收敛作用。该中心包括4个项目和4个核心,它们整合流行病学,临床和动物模型以解决中心假设。该中心研究通过青春期遵循心理和身体健康问题,在子宫内暴露于子宫内的儿童。一个伴侣项目使用多模式神经影像学和脑电图研究了在子宫内暴露于SSRI的新生儿,以评估最早的大脑结构和功能。在小鼠模型中使用相同的多模式成像指标以及对可能基于成像异常的细胞性质的显微镜分析研究了早期SSRI暴露的大脑效应。在早期开发过程中可能会编码5HT遗传调节剂的影响的中心原因。我们通过遗传分层的新生儿和胎儿鼠尾草猕猴来检验这一假设,并以独特的,临床表征的,抑郁症的高风险和低风险检查遗传学,脑成像和脑电图。对早期5HT信号传导和大脑发育的中心研究应更好地理解某些精神障碍是否起源于发展,这是一个与NIMH任务高度相关的问题。 公共卫生相关性:估计表明,在美国,> 100,000名婴儿在子宫内暴露于子宫内,但实际上,SSRI对胎儿大脑或其长期后果的影响几乎一无所知。 5-羟色胺在大脑发育中的作用显然在其他物种中确定,也可能应用于人类。拟议的中心将解决有关SSRI对胎儿的长期影响的重要公共卫生问题,并更好地了解5-羟色胺如何影响大脑的成熟和行为。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAY A GINGRICH其他文献

JAY A GINGRICH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAY A GINGRICH', 18)}}的其他基金

Serotonergic modulation of claustro-cortical circuits
幽闭皮质回路的血清素调节
  • 批准号:
    8726489
  • 财政年份:
    2013
  • 资助金额:
    $ 200万
  • 项目类别:
Serotonergic modulation of claustro-cortical circuits
幽闭皮质回路的血清素调节
  • 批准号:
    8584120
  • 财政年份:
    2013
  • 资助金额:
    $ 200万
  • 项目类别:
Project 4: Serotonin-mediated genetic and pharmacologic influences on developing
项目 4:血清素介导的遗传和药理学对发育的影响
  • 批准号:
    8059843
  • 财政年份:
    2010
  • 资助金额:
    $ 200万
  • 项目类别:
Serotonergic Modulation of Brain Development: Genetic and Pharmacologic Influenc
大脑发育的血清素调节:遗传和药理影响
  • 批准号:
    8478200
  • 财政年份:
    2010
  • 资助金额:
    $ 200万
  • 项目类别:
Serotonergic Modulation of Brain Development: Genetic and Pharmacologic Influenc
大脑发育的血清素调节:遗传和药理影响
  • 批准号:
    8661053
  • 财政年份:
    2010
  • 资助金额:
    $ 200万
  • 项目类别:
Serotonergic Modulation of Brain Development: Genetic and Pharmacologic Influenc
大脑发育的血清素调节:遗传和药理影响
  • 批准号:
    8269763
  • 财政年份:
    2010
  • 资助金额:
    $ 200万
  • 项目类别:
Serotonergic Modulation of Brain Development: Genetic and Pharmacologic Influenc
大脑发育的血清素调节:遗传和药理影响
  • 批准号:
    8135993
  • 财政年份:
    2010
  • 资助金额:
    $ 200万
  • 项目类别:
Core 1: Administrative Data Management Core
核心 1:行政数据管理核心
  • 批准号:
    8059824
  • 财政年份:
    2010
  • 资助金额:
    $ 200万
  • 项目类别:
Serotonin and the Modulation of Brain Development
血清素和大脑发育的调节
  • 批准号:
    8197718
  • 财政年份:
    2008
  • 资助金额:
    $ 200万
  • 项目类别:
Serotonin and the Modulation of Brain Behavior
血清素和大脑行为的调节
  • 批准号:
    10355521
  • 财政年份:
    2008
  • 资助金额:
    $ 200万
  • 项目类别:

相似国自然基金

基于动态相位调制的高能效光学脑机接口芯片关键技术
  • 批准号:
    62374109
  • 批准年份:
    2023
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
新型载波-调制式运动意识脑电信号解码方法研究
  • 批准号:
    82172057
  • 批准年份:
    2021
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
运动参数想象对脑电微状态的调制机制和识别方法研究
  • 批准号:
    82060329
  • 批准年份:
    2020
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
基于个性化空间编码调制的视觉脑-机接口方法研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    64 万元
  • 项目类别:
基于晶体相位调制原理研究具有高信噪比、高灵敏度的低频脑电检测方法
  • 批准号:
    61875152
  • 批准年份:
    2018
  • 资助金额:
    63.0 万元
  • 项目类别:
    面上项目

相似海外基金

Serotonergic modulation of the circuits and cell-types of the lateral habenula
外侧缰核电路和细胞类型的血清素调节
  • 批准号:
    10713125
  • 财政年份:
    2023
  • 资助金额:
    $ 200万
  • 项目类别:
Coordinated modulation of cortical circuits by serotonin and acetylcholine
血清素和乙酰胆碱对皮质回路的协调调节
  • 批准号:
    10665047
  • 财政年份:
    2021
  • 资助金额:
    $ 200万
  • 项目类别:
Serotonergic modulation of nucleus reuniens in affective and cognitive behaviors
情感和认知行为中团聚核的血清素调节
  • 批准号:
    10303284
  • 财政年份:
    2021
  • 资助金额:
    $ 200万
  • 项目类别:
CRCNS: A mechanistic theory of serotonergic modulation of cortical processing
CRCNS:皮质处理的血清素调节机制理论
  • 批准号:
    10645069
  • 财政年份:
    2021
  • 资助金额:
    $ 200万
  • 项目类别:
CRCNS: A mechanistic theory of serotonergic modulation of cortical processing
CRCNS:皮质处理的血清素调节机制理论
  • 批准号:
    10435584
  • 财政年份:
    2021
  • 资助金额:
    $ 200万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了